title: Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.
authors.affiliation: University of Florida College of Medicine-Jacksonville, 655 West 8th Street, Jacksonville, FL 32209, USA.
authors.forename: Antonio
authors.initials: A
authors.lastname: Tello-Montoliu
authors.forename: Fabiana
authors.initials: F
authors.lastname: Rollini
authors.forename: Bhaloo
authors.initials: B
authors.lastname: Desai
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pasqualino
authors.forename: Ronakkumar
authors.initials: R
authors.lastname: Patel
authors.forename: Alexandra Santana
authors.initials: AS
authors.lastname: Sorensen
authors.forename: Kjell S
authors.initials: KS
authors.lastname: Sakariassen
authors.forename: Dominick J
authors.initials: DJ
authors.lastname: Angiolillo
mesh_terms: D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy; D001792:Blood Platelets / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013928:Thromboxane A2 / Q000097:blood; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D044244:Receptors, Thromboxane A2, Prostaglandin H2; D013928:Thromboxane A2; D013930:Thromboxane-A Synthase